期刊文献+

人甲状腺受体相互作用蛋白15基因全长cDNA的克隆及其特性 被引量:5

Full-length cDNA Cloning and Identification of the Characteristics of Human Thyroid Receptor Interacting Protein 15 Gene
下载PDF
导出
摘要 通过生物信息学分析及RT PCR技术 ,从人垂体cDNA文库中克隆到甲状腺素受体相互作用蛋白 15(hTRIP15)的全长cDNA ,长度 1963bp ,编码 4 4 3氨基酸 ,同时克隆该基因不同剪接方式所形成的新的异构体 ,长度 1984bp ,编码 4 50氨基酸 .与基因组序列比较显示该基因具有 12个外显子 ,5号外显子 3′端具有 2个剪切的接点 (-ag) .搜寻UniGene数据库作染色体定位于D15S146 D15S117,该基因在生物进化上具有较高的保守性 ,从单细胞藻类到人类均有该基因同源物表达 ,亚细胞定位为核内 .Northern杂交显示 ,该基因具有 3种不同大小的转录本 ,分别约为 2 0、3 5及 4 0kb ,且在人体各组织中均有一定表达 ,其中骨骼肌、心脏及肾脏组织为高表达 .半定量RT PCR显示在一些内分泌组织均有表达 ,以肾上腺较高 . By bioinformatics and RT\|PCR procedures,the full\|length cDNA of human thyroid interacting protein 15(hTRIP15),spanning 1 963 bp and encoding 443 amino acids,was cloned from human pituitary cDNA library,and a novel isoform by alternative splicing was also cloned,which had 1 984 bp in length with 450 amino acids.The gene had 12 exons and there were two splicing adaptors(-ag) in the 3′ end of the 5th exon as compared with genomic DNA sequence.hTRIP15 was localized in D15S146\|D15S117 by Unigene searching and conserved in bioevolution from single\|cell organism to human being.The protein encoded by the gene was expressed in nucleus.Northern bloting showed that there were three transcripts in most human tissues and the gene was highly expressed in the skeletal muscle,heart,kidney as well as adrenal tissues.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2001年第5期563-568,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金资助项目 (No .3 9970 3 70 )
关键词 hTRIP15 CDNA克隆 亚细胞定位 组织表达谱 染色体定位 人甲状腺素 受体相互作用蛋白15 hTRIP15,cDNA cloning,subcellular localization,tissue expression pattern,chromosome localization
  • 相关文献

参考文献3

  • 1Wei N,Photochem Photobiol,1998年,68卷,2期,237页
  • 2Tang M X,Bioconjugate Chem,1996年,7卷,6期,703页
  • 3Lee J W,Mol Endocrinol,1995年,9卷,2期,243页

同被引文献44

  • 1ISE T, NAGATANI G, IMAMURA T, et al. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen[J]. Cancer Res, 1999, 59(2): 342-346.
  • 2MONTANI V, TANIGUCHI S I, SHONG M, et al. Major histocompatibility class Ⅱ HLA-DR alpha gene expression in thyrocytes: counter regulation by the class Ⅱ transactivator and the thyroid Y box protein[J]. Endocrinology, 1998, 139 (1): 280-289.
  • 3MACDONALD G H, ITOH-LINDSTROM Y, TING J P. The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter[J]. J Biol Chem,1995, 270(8): 3527-3533.
  • 4OHMORI M, SHIMURA H, SHIMURA Y, et al. A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression[J]. Mol Endocrinol, 1996, 10( 1 ):76-89.
  • 5OZER J, FABER M, CHALKLEY R, et al. Isolation and characterization of a cDNA clone for the CCAAT transcription factor EFIA reveals a novel structural motif[J]. J Biol Chem,1990, 265 (36): 22143-22152.
  • 6McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology [J]. Endocr Rev, 1999,20(3): 321-344.
  • 7彭永德 张新 宋怀东.用酵母双杂交技术研究hTRIP 15与TR的相互作用.中华内分泌学代谢杂志,2003,19(2):95-97.
  • 8Rastinejad F, Perlmann T, Evans RM, et al. Structural determinants of nuclear receptor assembly on DNA direct repeats [J]. Nature, 1995,375(6528): 203-211.
  • 9Lee JW, Choi HS, Gyuris J,et al.Asses of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor[J]. Mol Endocrinol, 1995,9(2): 243-254.
  • 10Akiyama H, Sugiyama A, Uzawa K, et al. Implication of trip15/CSN2 in early stage of neuronal differentiation of p19 embryonal carcinoma cells [J]. Brain Res Dev Brain Res, 2003,140(1): 45-56.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部